Dashboard
Manage Tickers

RLAY Relay Therapeutics, Inc.

Nasdaq relaytx.com


$ 6.50 $ -0.02 (-0.31 %)    

Friday, 17-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 6.49
$ 6.41
$ 6.25 x 500
$ 6.90 x 500
$ 6.31 - $ 6.63
$ 1.78 - $ 7.00
1,963,889
na
1.12B
$ 1.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-05-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-27-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

guggenheim-assumes-relay-therapeutics-at-buy-announces-price-target-of-15
Guggenheim Assumes Relay Therapeutics at B...
09/04/2025 14:10:24

Guggenheim analyst Brad Canino assumes Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $15.

medtronic-to-rally-around-25-here-are-10-top-analyst-forecasts-for-tuesday
Medtronic To Rally Around 25%? Here Are 10...
08/26/2025 13:40:26

hc-wainwright--co-maintains-buy-on-relay-therapeutics-lowers-price-target-to-14
HC Wainwright & Co. Maintains Buy on Relay...
08/26/2025 11:12:30

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

raymond-james-maintains-strong-buy-on-relay-therapeutics-lowers-price-target-to-19
Raymond James Maintains Strong Buy on Rela...
08/08/2025 16:14:14

Raymond James analyst Dane Leone maintains Relay Therapeutics (NASDAQ:RLAY) with a Strong Buy and lowers the price target fr...

relay-therapeutics-q2-eps-041-beats-048-estimate-sales-677000k-beat-54545k-estimate
Relay Therapeutics Q2 EPS $(0.41) Beats $(...
08/07/2025 20:10:53

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

preview-relay-therapeuticss-earnings
Preview: Relay Therapeutics's Earnings
08/06/2025 18:09:09

relay-therapeutics-says-updated-interim-clinical-data-for-rly-2608-remain-consistent-showing-103-month-median-pfs-overall-and-110-month-median-pfs-in-2l-patients-with-pi3k-mutated-hrher2--metastatic-breast-cancer
Relay Therapeutics Says Updated Interim Cl...
06/02/2025 11:03:24

Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L patients with PI3...

guggenheim-maintains-buy-on-relay-therapeutics-lowers-price-target-to-10
Guggenheim Maintains Buy on Relay Therapeu...
05/07/2025 15:16:04

Guggenheim analyst Michael Schmidt maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $3...

relay-therapeutics-q1-eps-046-beats-048-estimate-sales-768m-beat-1000k-estimate
Relay Therapeutics Q1 EPS $(0.46) Beats $(...
05/05/2025 20:16:28

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(...

this-twin-disc-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Twin Disc Analyst Begins Coverage On ...
04/17/2025 12:50:40

wells-fargo-initiates-coverage-on-relay-therapeutics-with-equal-weight-rating-announces-price-target-of-4
Wells Fargo Initiates Coverage On Relay Th...
04/17/2025 12:04:56

Wells Fargo initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Equal-Weight rating and announces Price Target of $4.

hc-wainwright--co-reiterates-buy-on-relay-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Rela...
03/07/2025 12:38:12

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $16 price ...

goldman-sachs-maintains-buy-on-relay-therapeutics-lowers-price-target-to-18
Goldman Sachs Maintains Buy on Relay Thera...
02/27/2025 17:03:58

Goldman Sachs analyst Salveen Richter maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from...

stifel-maintains-buy-on-relay-therapeutics-lowers-price-target-to-23
Stifel Maintains Buy on Relay Therapeutics...
02/27/2025 15:37:29

Stifel analyst Bradley Canino maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $27 to ...

relay-therapeutics-q4-gaap-eps-045-beats-058-estimate
Relay Therapeutics Q4 GAAP EPS $(0.45) Bea...
02/26/2025 21:27:44

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(...

earnings-scheduled-for-february-26-2025
Earnings Scheduled For February 26, 2025
02/26/2025 08:32:32

hc-wainwright--co-reiterates-buy-on-relay-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Rela...
01/14/2025 12:58:19

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $16 price ...

relay-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--135
Relay Therapeutics Shares Halted On Circui...
01/10/2025 18:55:33

relay-therapeutics-shares-resume-trade
Relay Therapeutics Shares Resume Trade
01/10/2025 18:49:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION